AMPR-22 is a 22-residue antimicrobial-like peptide enriched in cationic and hydrophobic side chains that support membrane interaction. Amphipathic organization favors helix formation in lipid mimetics. Researchers evaluate its ability to perturb bilayers, aggregate, and bind biomacromolecules. Applications include host-defense peptide modeling, membrane biophysics, and sequence-activity optimization.
AMPR-22 is a synthetic antimicrobial peptide engineered to mimic and enhance the natural host-defense mechanisms found in biological systems. As a member of the peptide family, it is structurally characterized by a sequence that confers potent activity against a broad spectrum of microbial targets. Its amphipathic nature and cationic charge facilitate interactions with microbial membranes, making it a valuable asset for researchers investigating innate immunity, microbial resistance, and peptide-based antimicrobial strategies. The compound's stability and defined sequence allow for reproducible results in experimental settings, positioning it as a versatile tool for both fundamental and applied biochemical studies.
Antimicrobial mechanism studies: AMPR-22 serves as an important model for dissecting the molecular basis of peptide-mediated antimicrobial action. Researchers utilize it to explore how cationic peptides disrupt bacterial membranes, leading to cell lysis or inhibition of microbial growth. Its defined structure enables systematic analysis of structure-activity relationships, helping to elucidate the physicochemical features that govern selective targeting of microbial versus eukaryotic membranes. Such studies provide critical insights into the mechanisms underlying antimicrobial resistance and inform the rational design of next-generation peptide antibiotics.
Peptide-membrane interaction research: The compound is frequently employed in biophysical and biochemical investigations focused on peptide-membrane interactions. Its amphipathic configuration and charge distribution make it an ideal candidate for probing the dynamics of peptide insertion, translocation, and aggregation within lipid bilayers. Researchers leverage these properties to examine membrane permeabilization, pore formation, and lipid-specific binding, contributing to a deeper understanding of membrane-active peptides and their potential applications in biotechnology.
Antimicrobial peptide screening and development: AMPR-22 is often integrated into high-throughput screening platforms and comparative studies aimed at identifying novel antimicrobial peptides with improved efficacy or stability. By serving as a reference or benchmark peptide, it enables the evaluation of analogs, derivatives, and hybrid constructs. This application supports the iterative optimization of sequence motifs, post-translational modifications, and delivery strategies, ultimately advancing the field of peptide-based antimicrobial development.
Biofilm inhibition assays: The peptide is also utilized in studies investigating the prevention and disruption of microbial biofilms, which represent a significant challenge in both environmental and industrial contexts. Its ability to interfere with biofilm formation or promote biofilm dispersal is assessed using standardized in vitro models, allowing researchers to quantify efficacy and elucidate underlying mechanisms. These findings support the development of peptide-based solutions for biofilm control in medical devices, water treatment systems, and food processing environments.
Peptide synthesis and analytical validation: AMPR-22 is valuable for optimizing solid-phase peptide synthesis protocols and validating analytical methods such as HPLC and mass spectrometry. Its well-characterized sequence and physicochemical properties facilitate method development, process validation, and quality control in peptide production workflows. This role is particularly relevant for laboratories and companies engaged in custom peptide synthesis, as it provides a reliable reference point for troubleshooting and ensuring reproducibility across batches.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More